Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue
+4.59%
EPS
+128.9%
Free cash flow
−9.03%
Total debt
−4.51%

Quarter to September 2026, against a year earlier

15.14 0.51 −3.26%
Market cap
$10.3B
P/E
30.3×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a

Avantor, Inc. (AVTR) Free cash flow

Alert me on Free cash flow

Avantor, Inc.'s free cash flow for fiscal 2025 was $495.0M, down 28.5% from $692.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $439.2M. Over the past ten years it has ranged from −$192.7M (fiscal 2017) to $868.2M (fiscal 2020); the current reading is higher than 50% of that period. Avantor, Inc. ranks 10th of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $495.0M (28.47%)
FY2024 $692.0M (4.37%)
FY2023 $723.6M 1.89%
FY2022 $710.2M (15.70%)
FY2021 $842.5M (2.96%)
FY2020 $868.2M 187.10%
FY2019 $302.4M 85.75%
FY2018 $162.8M —
FY2017 −$192.7M —
FY2016 $72.9M —

Quarterly newest first

Period Free cash flow Change
Sep 2026 $156.2M 11.10%
Jun 2026 $140.6M 457.94%
Mar 2026 $25.2M (78.50%)
Dec 2025 $117.2M (31.74%)
31 more quarters

Against its own ten years

Low −$192.7M High $868.2M
Ten-year median $593.5M
Current reading's percentile 50

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on AVTR